2nd Quarter - Report
ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION
Firm
Client
Income
—
Expenses
$65,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1600 Patients' Access to Treatments Act HR 6 21st Century Cures/Innovation for Healthier Americans HR 1859 Physician Workforce/Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Medicare/Medicaid MMM
Medicare Part B and D HR 775/S 539 Medicare Access to Rehabilitation Services Act of 2015 Medicaid CHIP CHIP Re-authorization SGR HR 1470/S 810 SGR Repeal DoD
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Budget/Appropriations BUD
FY 16 appropriations for HHS, CDC, NIH, DoD FY 16 budget and appropriations Budget Control Act Bipartisan Budget Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.